ResMed logo

ResMed Income Statement

Revenue, expenses, and profitability over time

ResMed generated $5.5B in trailing twelve-month revenue, up 0.1% year-over-year. Net income was $1.5B with a 27.44% net margin. Gross margin stands at 61.59% and operating margin at 34.18%. Diluted EPS is $10.37, which grew 0.2% year-over-year. Based on the Q1 2026 filing.

Latest FilingQ1 2026
Report Date2026-04-30
Market Cap$29.6B
P/E Ratio19.49
ROE25.25%

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Capital Expenditures$20.6M$20.8M$30.6M$43.0M$28.5M$33.7M
Change in Accounts Receivable$67.9M$40.0M$5.2M-$30.0M$72.7M$16.9M
Income Taxes Paid, Net$118.6M-$26.5M$16.2M$61.9M$147.5M$71.7M
Interest Paid, Net-$66.0K$14.2M$6.9M$6.9M$6.6M$6.5M
Gain on insurance recoveries$0.0$0.0$0.0
Income Taxes Paid, Net$118.6M-$26.5M$16.2M$61.9M$147.5M$71.7M
Accounts payable and other current liabilities$4.2M$63.1M$49.1M$7.6M$10.6M$103.9M
Increase (Decrease) in Accounts Receivable$67.9M$40.0M$5.2M-$30.0M$72.7M$16.9M
Increase (Decrease) in Inventories$7.6M-$29.9M$32.1M$14.7M-$26.1M-$12.5M
Increase (Decrease) in Prepaid Expense and Other Assets$43.6M-$79.4M-$47.0M-$2.3M$106.4M$48.3M
Interest Paid, Excluding Capitalized Interest, Operating Activity-$66.0K$14.2M$6.9M$6.9M$6.6M$6.5M
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation-$147.5M-$144.1M-$163.9M-$230.3M-$258.3M-$255.2M
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation-$36.7M-$31.8M-$133.7M-$52.6M-$50.9M-$58.0M
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation$308.6M$578.7M$538.8M$457.3M$339.7M$554.1M
Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1$0.0$0.0$6.3M
Payments for (Proceeds from) Derivative Instrument, Investing Activities$11.8M$5.9M-$40.4M$4.1M$12.4M-$24.1M
Payments for Repurchase of Common Stock$75.0M$75.0M$100.0M$150.0M$175.0M$175.0M
Payments of Dividends$77.7M$77.7M$77.6M$87.8M$87.6M$87.2M
Payments of Merger Related Costs, Financing Activities$0.0$0.0$0.0$0.0$0.0$0.0
Payment related to business acquisition$670.0K$0.0$138.6M$522.0K$0.0$24.9M
Payments to Acquire Businesses, Net of Cash Acquired$670.0K$0.0$138.6M$522.0K$0.0$24.9M
Payments to Acquire Intangible Assets-$1.8M$0.0$10.8M$2.8M-$1.3M$0.0
Payments to Acquire Investments$1.0M$2.1M$2.0M$2.2M$4.2M$20.1M
Payments to Acquire Property, Plant, and Equipment$20.6M$20.8M$30.6M$43.0M$28.5M$33.7M
Proceeds from Issuance of Common Stock$26.9M$9.0M$30.2M$8.2M$29.6M$7.4M
Repayments of Long-Term Debt$5.0M$0.0$5.0M$0.0$5.0M$0.0
Stock-based compensation$22.6M$24.1M$24.8M$21.2M$28.9M$26.8M

Net Income

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Net income$344.6M$365.0M$379.7M$348.5M$392.6M$398.7M